rs386833720
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001042432.2(CLN3):c.424delG(p.Val142LeufsTer39) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,613,904 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001042432.2 frameshift
Scores
Clinical Significance
Conservation
Publications
- inherited retinal dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- neuronal ceroid lipofuscinosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- neuronal ceroid lipofuscinosis 3Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CLN3 | NM_001042432.2 | c.424delG | p.Val142LeufsTer39 | frameshift_variant | Exon 7 of 16 | ENST00000636147.2 | NP_001035897.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152062Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251294 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461842Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727228 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152062Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74278 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Neuronal ceroid lipofuscinosis 3 Pathogenic:4
- -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
- -
- -
Neuronal ceroid lipofuscinosis Pathogenic:2
This sequence change creates a premature translational stop signal (p.Val142Leufs*39) in the CLN3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CLN3 are known to be pathogenic (PMID: 9311735, 28542676). This variant is present in population databases (rs386833720, gnomAD 0.0009%). This premature translational stop signal has been observed in individuals with juvenile-onset neuronal ceroid lipofuscinosis (JNCL) (PMID: 9311735, 17947292, 20187884). ClinVar contains an entry for this variant (Variation ID: 56269). For these reasons, this variant has been classified as Pathogenic. -
Variant summary: CLN3 c.424delG (p.Val142LeufsX39) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 4e-06 in 251294 control chromosomes (gnomAD). c.424delG has been reported in the literature in the compound heterozygous or homozygous state in multiple individuals affected with Juvenile Neuronal Ceroid-Lipofuscinosis (Juvenile Batten Disease) (e.g. Kousi_2012, Munroe_1997). These data indicate that the variant is very likely to be associated with disease. Two ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at